• Increase font size
  • Default font size
  • Decrease font size

Rite Aid Reports 0.6 Percent Same Store Sales Decrease for June

Print E-mail
Thursday, 02 July 2009 08:23
http://www.riteaid.com CAMP HILL, Pa.--Rite Aid Corporation (NYSE:RAD) today announced sales results for June.

Monthly Sales

For the four weeks ended June 27, 2009, same store sales decreased 0.6 percent over the prior year period. June front-end same store sales decreased 4.5 percent while pharmacy same store sales, which included an approximate 484 basis points negative impact from new generic introductions, increased 1.4 percent.

For the four weeks ended June 27, 2009, same store sales excluding the acquired Brooks Eckerd stores were flat compared to the prior-year period with front-end same store sales decreasing 4.4 percent and pharmacy same store sales increasing 2.6 percent.

For the four weeks ended June 27, 2009, same store sales at the acquired Brooks Eckerd stores declined 1.8 percent over the prior-year period with front-end same store sales decreasing 5.0 percent and pharmacy same store sales decreasing 0.7 percent.

Total drugstore sales for the four-week period decreased 2.5 percent to $1.973 billion compared to $2.023 billion for the same period last year. Prescription revenue accounted for 67.9 percent of drugstore sales, and third party prescription revenue represented 96.3 percent of pharmacy sales.

Year-to-Date Sales

Same store sales for the 17-week period ended June 27, 2009 increased 0.3 percent, consisting of a 2.3 percent decrease in front-end same store sales and a 1.6 percent increase in pharmacy same store sales.

Total drugstore sales for the 17 weeks ended June 27, 2009 decreased 1.5 percent to $8.479 billion compared to $8.610 billion in last year’s like period. Prescription revenue represented 68.1 percent of total drugstore sales, and third party prescription revenue was 96.3 percent of pharmacy sales.

Rite Aid is one of the nation’s largest drugstore chains. On June 27, 2009, the company operated 4,822 stores compared to 4,988 stores in the like period a year ago. Information about Rite Aid, including corporate background and press releases, is available through the company’s website at http://www.riteaid.com.




BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 
about 6 hours ago Illumina’s Board Unanimously Rejects Roche’s Offer; Shire Announces FDA Approval of Vyvanse®: Below is a look at... http://t.co/L3FZivQV
about 14 hours ago Achillion ($ACHN) hammered after BofA rates to "Underperform" citing no M&A speculation. What we said last month: http://t.co/usWk95O6
about 1 day ago Medgenics ($MDGN) up 10% on Monday! We first told you about the firm last Friday: http://t.co/aD50CMSH
about 1 day ago Thinly traded BioLineRx shares move on hepatitis C deal: The shares of thinly traded BioLineRx (NASDAQ:BLRX) soa... http://t.co/ugbuZgNN
about 1 day ago Orexigen® Announces Agreement From the FDA on a Special Protocol Assessment; Acorda Announces Launch of Generic ... http://t.co/vSt6VrLP
about 1 day ago $CVM up 17% and technically looks like it may head higher.
about 1 day ago $ANAC drops after GlaxoSmithKline (GSK) pauses enrollment for its clinical trials of its urinary tract infection drug. http://t.co/yUUSzkUr
about 1 day ago Catalysts on tap for Corcept: Corcept Therapeutics (NASDAQ:CORT) is a drug discovery company focused on the deve... http://t.co/jd3C1ddH

navigation

Free Phone Trade Alerts